One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock

One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock

Background: We aimed to evaluate the effect of intravenous glycoprotein IIb/IIIa receptor inhibitors (GPIs) on in-hospital survival and mortality during and at the 1-year follow-up in patients undergoing percutaneous coronary intervention (PCI) for myocardial infarction (MI) complicated by cardiogen...

Full description

Bibliographic Details
Main Authors: Krzysztof Myrda, Mariusz Gąsior, Dariusz Dudek, Bartłomiej Nawrotek, Jacek Niedziela, Wojciech Wojakowski, Marek Gierlotka, Marek Grygier, Janina Stępińska, Adam Witkowski, Maciej Lesiak, Jacek Legutko
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
acute coronary syndrome
cardiogenic shock
glycoprotein IIb/IIIa receptor inhibitors
myocardial infarction
percutaneous coronary intervention
Online Access:https://www.mdpi.com/2077-0383/10/21/5059

Internet

https://www.mdpi.com/2077-0383/10/21/5059

Similar Items